Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC in $7.75 Million Initial Public Offering of Common Stock of Cel-Sci Corp.

Press Release – New York, NY – February 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ThinkEquity LLC in the initial public offering of the common stock of Cel-Sci Corp. (NASDAQ: CVM) (the “Company”), a phase 3 cancer immunotherapy company. The offering consisted of 3,875,000 shares of the Company’s common stock at a public offering price of $2.00 per share, for gross proceeds of approximately $7.75 million. The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-265995), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2022 and declared effective on July 15, 2022. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Phil Magri, and counsel Jeffrey Hua.